同源康医药(02410.HK):一股东持460.8万股非上市股份转换H股 完成中证监备案

阿斯达克财经
Jan 26

同源康医药-B(02410.HK) 公布,近日,中国证监会已就H股全流通向公司发出备案通知书。1名股东持有460.8万股非上市股份转换为相同数目H股的H股全流通的中国证监会备案已告完成。于完成有关转 换及联交所授予上市批准后,该等460.8万股H股将于联交所主板上市及买卖。 备案通知书将自中国证监会核准之日起12个月内有效。H股全流通的实施计划详情尚未最终确定。(hc/w)(港股报价延迟最少...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10